Uncategorized
Omeros receives marketing authorization for Omidria in European Union
The European Commission has granted marketing authorization for Omidria for use in cataract surgery and lens replacement procedures in the European Union, Omeros announced in a press release. The approval allows for the marketing of Omidria (phenylephrine 1% and ketorolac 0.3%) in all EU member states and also Iceland, Lichtenstein and Norway.